Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro
Open Access
- 19 July 2014
- journal article
- research article
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 13 (1) , 97
Abstract
Local slow release implant provided long term and stable drug release in the lesion. The objective of this study was to fabricate biodegradable slow release INH/PLLA tablet via 3 dimensional printing technique (3DP) and to compare the drug release characteristics of three different structured tablets in vitro. Three different drug delivery systems (columnar-shaped tablet (CST), doughnut-shaped tablet (DST) and multilayer doughnut-shaped tablet (MDST)) were manufactured by the three dimensional printing machine and isoniazid was loaded into the implant. Dynamic soaking method was used to study the drug release characteristics of the three implants. MTT cytotoxicity test and direct contact test were utilized to study the biocompatibility of the implant. The microstructures of the implants’ surfaces were observed with electron microscope. The PLLA powder in the tablet could be excellently combined through 3DP without disintegration. Electron microscope observations showed that INH distributed evenly on the surface of the tablet in a “nest-shaped” way, while the surface of the barrier layer in the multilayer doughnut shaped tablet was compact and did not contain INH. The concentration of INH in all of the three tablets were still higher than the effective bacteriostasis concentration (Isoniazid: 0.025 ~ 0.05 μg/ml) after 30 day’s release in vitro. All of the tablets showed initial burst release of the INH in the early period. Drug concentration of MDST became stable and had little fluctuation starting from the 6th day of the release. Drug concentration of DST and CST decreased gradually and the rate of decrease in concentration was faster in DST than CST. MTT cytotoxicity test and direct contact test indicated that the INH-PLLA tablet had low cytotoxicity and favorable biocompatibility. Three dimensional printing technique was a reliable technique to fabricate complicated implants. Drug release pattern in MDST was the most stable among the three implants. It was an ideal drug delivery system for the antibiotics. Biocompatibility tests demonstrated that the INH-PLLA implant did not have cytotoxicity. The multilayer donut-shaped tablet provided a new constant slow release method after an initial burst for the topical application of the antibiotic.Keywords
This publication has 21 references indexed in Scilit:
- Biodegradable three-dimension micro-device delivering 5-fluorouracil in tumor bearing miceDrug Delivery, 2011
- Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization abilityActa Biomaterialia, 2011
- 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviorsJournal of Controlled Release, 2010
- A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapyBiomedical Materials, 2009
- Three-Dimensional Printing Creates Models for Surgical Planning of Aortic Valve Replacement After Previous Coronary Bypass GraftingThe Annals of Thoracic Surgery, 2008
- Low temperature direct 3D printed bioceramics and biocomposites as drug release matricesJournal of Controlled Release, 2007
- Ofloxacin‐delivery system of a polyanhydride and polylactide blend used in the treatment of bone infectionJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2007
- Controlled release from triple layer, donut-shaped tablets with enteric polymersAAPS PharmSciTech, 2005
- Preparation and Characterization of Chitosan-Based NanoparticlesBiomacromolecules, 2005
- Three‐dimensional printing of porous ceramic scaffolds for bone tissue engineeringJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2005